Meanwhile, working with Neuro-Bio, Aptamer has developed optimer binders to a novel Alzheimer’s disease ... signing multiple new contracts with global market-leading pharmaceutical companies, many of ...

The company, noted for its novel Optimer® binders to enable innovation ... signing multiple new contracts with global market-leading pharmaceutical companies, many of which represent repeat ...

Meanwhile, working with Neuro-Bio, Aptamer has developed optimer binders to a novel Alzheimer ... new contracts with global market-leading pharmaceutical companies, many of which represent ...

WASHINGTON, March 24 (Reuters) - U.S. President Donald Trump said on Monday he will in the very near future announce tariffs on automobiles, aluminum and pharmaceuticals. Speaking to reporters at ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Pharma 4.0 - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Pharma 4 was valued ...

Jazz Pharmaceuticals (JAZZ) and Chimerix (CMRX) announced the companies have entered into a definitive agreement for Jazz to acquire Chimerix for $8.55 per share in cash, representing a total ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

For years, Jeff Simmons — the president and CEO of the large US pharmaceutical company Elanco — ridiculed a seemingly unlikely target on social media: the plant-based meat industry.

Pharmaceutical companies control and hide information from their clinical trials, preventing health care professionals from making the most informed decisions to best treat patients. The newly ...